Skip to content
healthcare.dev

Vizamyl

NDC 17156-067, Flutemetamol F-18, solution, from GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare).

Product NDC
17156-067
Status
Listed
Labeler
GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare)
Dosage form
SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA203137
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17156-067 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FLUTEMETAMOL F-184.05 mCi/mL

Pharmacologic classes

Radioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]

Package NDCNDC-11Package
17156-067-30171560067301 VIAL, MULTI-DOSE in 1 CONTAINER (17156-067-30) / 30 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b3558f16-8f9a-4e55-8d9c-836427ebaa57

Use it

Look up 17156-067 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17156-067 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17156-067. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.